CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

BioSpace
Original article

Sandoz inks $322M Henlius deal for rights to as many as 10 biosimilars

PartnershipPositive
AI Analysis

Summary

Sandoz has entered into a $322M agreement with Henlius to acquire rights to up to 10 biosimilars, including copies of drugs from Amgen, Eli Lilly, and GSK that generate billions in annual revenues.

Importance:7/10
Sentiment:
0.60
biosimilarslicensingdealpartnership
Related Companies

Read the original article

Published by BioSpace on August 18, 2026 1:33 PM

Read Original